Cem Demirkiran
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 27, 2025
Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.Cem Demirkiran, Stefania Bellone, Victoria M Ettorre
|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.Niccolò G Santin, Namrata Sethi, Stefania Bellone
|Apr 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma.Michelle Greenman, Cem Demirkiran, Stefania Bellone
|Sep 06, 2024
Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer.Tobias Max Philipp Hartwich, Miranda Mansolf, Cem Demirkiran
|Feb 10, 2024
Mitochondrial Unfolded Protein Response Gene <i>Clpp</i> Is Required for Oocyte Function and Female Fertility.Yagmur Ergun, Aysegul Gizem Imamoglu, Mauro Cozzolino
|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.Levent Mutlu, Diego D Manavella, Stefania Bellone
Pageof 1
Frequent Collaborators
5 joint publications
Alessandro D Santin
4 joint publications
Stefania Bellone
4 joint publications
Blair McNamara
3 joint publications
Victoria M Ettorre
3 joint publications
Namrata Sethi
3 joint publications
Tobias Max Philipp Hartwich
3 joint publications
Yang Yang-Hartwich
2 joint publications
Niccolo G Santin
2 joint publications
Natalia Buza
2 joint publications
Elena S Ratner
